Laura Conejero
Overview
Explore the profile of Laura Conejero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
497
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Robles-Vera I, Jarit-Cabanillas A, Brandi P, Martinez-Lopez M, Martinez-Cano S, Rodrigo-Tapias M, et al.
Immunity
. 2025 Jan;
58(2):381-396.e9.
PMID: 39848243
Impairment of the intestinal barrier allows the systemic translocation of commensal bacteria, inducing a proinflammatory state in the host. Here, we investigated innate immune responses following increased gut permeability upon...
2.
Saz-Leal P, Ligon M, Diez-Rivero C, Garcia-Ayuso D, Mohanty S, Vinuela M, et al.
Vaccines (Basel)
. 2024 May;
12(5).
PMID: 38793786
MV140 is an inactivated whole-cell bacterial mucosal vaccine with proven clinical efficacy against recurrent urinary tract infections (UTIs). These infections are primarily caused by uropathogenic (UPEC) strains, which are unique...
3.
Montalban-Hernandez K, Cogollo-Garcia A, Giron de Velasco-Sada P, Caballero R, Casanovas M, Subiza J, et al.
Vaccines (Basel)
. 2024 Feb;
12(2).
PMID: 38400155
Respiratory tract infections (RTIs) are among the most common and important problems in clinical medicine, making antibiotics the gold standard therapeutic option regardless of their frequent viral etiology. Their excessive...
4.
Saz-Leal P, Ligon M, Diez-Rivero C, Garcia-Ayuso D, Mohanty S, Conejero L, et al.
Res Sq
. 2023 Jun;
PMID: 37333312
MV140 is a mucosal vaccine of inactivated whole bacteria () with clinical efficacy against recurrent urinary tract infections (UTIs). Here, MV140 was evaluated in a murine model of acute uropathogenic...
5.
Nieto A, Nieto M, Conejero L, Subiza J
Curr Opin Allergy Clin Immunol
. 2022 Oct;
22(6):380-386.
PMID: 36305468
Purpose Of Review: To discuss recently discovered mechanisms of action of some bacterial vaccines that may account for their clinical benefit in the prevention of recurrent wheezing and asthma exacerbations...
6.
Brandi P, Conejero L, Cueto F, Martinez-Cano S, Dunphy G, Gomez M, et al.
Cell Rep
. 2022 Jan;
38(1):110184.
PMID: 34986349
MV130 is an inactivated polybacterial mucosal vaccine that confers protection to patients against recurrent respiratory infections, including those of viral etiology. However, its mechanism of action remains poorly understood. Here,...
7.
Sanchez-Ramon S, Fernandez-Paredes L, Saz-Leal P, Diez-Rivero C, Ochoa-Grullon J, Morado C, et al.
Front Immunol
. 2021 Jun;
12:675735.
PMID: 34149711
Introduction: Conventional or biologic disease-modifying anti-rheumatic drugs (DMARDs) are the mainstay of treatment for systemic autoimmune disease (SAD). Infectious complications are a major concern in their use. Objective: To evaluate...
8.
Nieto A, Mazon A, Nieto M, Calderon R, Calaforra S, Selva B, et al.
Am J Respir Crit Care Med
. 2021 Mar;
204(4):462-472.
PMID: 33705665
Recurrent wheezing in children represents a severe public health concern. Wheezing attacks (WA), mainly associated with viral infections, lack effective preventive therapies. To evaluate the efficacy and safety of mucosal...
9.
Singhania A, Graham C, Gabrysova L, Moreira-Teixeira L, Stavropoulos E, Pitt J, et al.
Nat Commun
. 2019 Jun;
10(1):2887.
PMID: 31253760
Understanding how immune challenges elicit different responses is critical for diagnosing and deciphering immune regulation. Using a modular strategy to interpret the complex transcriptional host response in mouse models of...
10.
Sanchez-Ramon S, Conejero L, Netea M, Sancho D, Palomares O, Subiza J
Front Immunol
. 2019 Jan;
9:2936.
PMID: 30619296
Challenge with specific microbial stimuli induces long lasting epigenetic changes in innate immune cells that result in their enhanced response to a second challenge by the same or unrelated microbial...